Sermorelin is a synthetic growth-hormone-releasing hormone fragment commonly described as GHRH(1-29) amide. Laboratory literature discusses it in relation to GHRH receptor activity, endocrine signalling models, growth-hormone pathway research, IGF-1-associated endpoint studies, and peptide structure-function comparisons.
As a 29-amino-acid GHRH analogue, Sermorelin is useful for controlled laboratory models focused on receptor signalling and peptide pathway mapping. Analytical documentation and batch COA data should remain the final reference for identity, purity, and salt form.
This product is supplied strictly for lawful research, laboratory, analytical, educational, or R&D purposes where permitted by applicable law. It is not intended for human or animal use.




